Biotech

All Articles

AvenCell bags $112M to snap 'switchable' CAR-Ts in the medical clinic

.AvenCell Therapies has gotten $112 million in set B funds as the Novo Holdings-backed biotech finds...

China- based biotech plans ph. 3 after viewing midstage eye data

.China-based Minghui Pharmaceutical has connected its own thyroid eye condition therapy to a decreas...

Sangamo slashes opportunity to market for Fabry genetics treatment as FDA accepts to accelerated approval deal

.Sangamo Therapies has actually determined a quick way to market for its Fabry illness applicant, al...

Otsuka's renal health condition drug strengthens UPCR levels in ph. 3 test

.Otsuka Pharmaceutical's kidney condition drug has actually hit the major endpoint of a phase 3 tria...

Roche throws out $120M tau possibility, giving back legal rights to UCB

.Roche has given back the rights to UCB's anti-tau antibody bepranemab, walking away from a $120 tho...

Editas reinforces in vivo approach by means of $238M Genenvant treaty

.Editas Medicines has actually authorized a $238 thousand biobucks deal to integrate Genevant Scienc...

Combo outcomes, Vicodin overlook and outstanding safety and security

.Tip has actually reported period 3 information on its own near-approval discomfort medication candi...

Angelini pens $360M biobucks treaty for ph. 1 mind ailment drug

.Italy's Angelini Pharma has signed a $360 million biobucks pact fixated a phase 1-stage mind wellne...

Sage gives up half of R&ampD team and agitates C-suite once more

.Sage Rehabs' most recent effort to reduce its own pipeline and labor force will certainly observe a...

With period 1 information, Mood possesses an eye on early-stage bladder cancer

.With its own lead candidate in a stage 3 trial for an unusual eye cancer cells, Feeling Biosciences...